Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a Phase 2, multi‐center, Investigator‐masked, randomized, parallel‐group study to evaluate the tolerability, efficacy and safety of VOS versus Restasis® over a 28‐day treatment period in subjects with mild to moderate DED. Approximately 90 subjects will be randomized to either VOS or Restasis® at approximately 7 centers located in the US
Epistemonikos ID: f33930b4c909dc18c5be9275340a9fd0023befef
First added on: May 21, 2024